Page 5 - Mologic Ltd News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Omega Notes CE Mark For Mologic's Rapid Covid-19 Test Thu, 24th Dec 2020 13:00 (Alliance News) - Omega Diagnostics Group PLC on Thursday said Mologic Ltd has received a CE mark for its professional-use Covid-19 rapid antigen test. Back in June, the London-listed medical diagnostics company signed a material transfer agreement with Mologic providing access to raw materials and know-how to manufacture the lateral flow antigen test. The test will provide healthcare professionals an accurate detection of the nucleoprotein of the SARS-CoV-2 virus in respiratory swabs. As announced at its interim r...

*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient: 1. Obtains access to the information in a personal capacity; 2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services; 3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional bod...

by Gemma Mackenzie © PRESS AND JOURNAL Sign up for our daily newsletter featuring the top stories from The Press and Journal. Thank you for signing up to The Press and Journal newsletter. Something went wrong - please try again later. Sign Up A new pen-side test to diagnose liver fluke in livestock in as little as 10 minutes is being developed by UK researchers. Scientists at the University of Liverpool are working with rapid diagnostic technology company Mologic Ltd to develop a new test for use by farmers, crofters and their vets. The liver fluke diagnostic tests currently ava...

Published: Dec 17, 2020 By Alex Keown In August, Russia approved Sputnik-V, a vaccine against COVID-19 ahead of the completion of Phase III studies. This week, the National Research Center for Epidemiology and Microbiology in that nation announced the vaccine’s efficacy is at 90% following the latest review of clinical data. The efficacy announcement followed an analysis of Phase III data. Calculation was based on the analysis of data of volunteers who received both the first and second doses of the Sputnik V vaccine or placebo at the third and final control point of 78 confirmed c...

New rapid diagnostic test developed for liver fluke 15 December 2020 | The new tool will provide rapid results, allowing farmers to make more informed decisions A new rapid diagnostic test has been developed which will enable diagnosis of liver fluke exposure in livestock in 10 minutes. Prevalent in over 70 countries and a common parasite affecting UK cattle and sheep, liver fluke is estimated to cause over $3.2bn in livestock production losses. Current liver fluke diagnostic tests require laboratory analysis, with typical wait time of week or more for results. Together with the impracticali...